EUVIMEDEUVIMED entdecken
Crossref

Lipid Nanoparticular Codelivery System for Enhanced Antitumor Effects by Ferroptosis–Apoptosis Synergistic with Programmed Cell Death-Ligand 1 Downregulation

Weiran Cao iD, Xue Zhang iD, Yaxuan Feng, Rui Li iD, An Lu, Zijie Li, Fei Yu, Lu Sun, Jiancheng Wang iD, Zhiyu Wang, Huining He iD

ACS Nano · 02.07.2024 · 18 (26) · 17267-17281

DOI: 10.1021/acsnano.4c04901 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 13.06.2024. Verfasst von Weiran Cao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, International Joint Laboratory of Ocular Diseas…. Hauptthemen laut MEDLINE: Ferroptosis, Nanoparticles, B7-H1 Antigen, Apoptosis. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Natural Science Foundation of Hebei Province, National Key Research and Development Program of China, Natural Science Foundation of Beijing Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisNanoparticlesB7-H1 AntigenApoptosisAntineoplastic AgentsDown-RegulationAnimalsHumansMiceReactive Oxygen SpeciesLipidsCell ProliferationFemaleDrug Screening Assays, AntitumorCell Line, TumorLiposomes

Stichwörter der Autor:innen

apoptosischemo-immune therapyferroptosisglutathione depletionreversing chemotherapy resistance

Substanzen

B7-H1 AntigenAntineoplastic AgentsReactive Oxygen SpeciesLipidsLipid NanoparticlesCD274 protein, humanLiposomes

Autor:innen und Institutionen

  • Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, International Joint Laboratory of Ocular Diseases, School of Pharmacy, School of Biomedical Engineering and Technolog…
  • Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
  • Department of Immuno-oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China.

ORCID-Profile: Weiran Cao, Xue Zhang, Rui Li, Jiancheng Wang, Huining He

Förderung

  • Natural Science Foundation of Hebei Province
  • National Key Research and Development Program of China
  • Natural Science Foundation of Beijing Municipality
  • Tianjin Municipal Science and Technology Committee
  • National Natural Science Foundation of China
  • Applied Basic Research Multi-Investment Foundation of Tianjin

Zitieren

APA

Cao, W., Zhang, X., Feng, Y., Li, R., Lu, A., Li, Z., Yu, F., Sun, L., Wang, J., Wang, Z., & He, H. (2024). Lipid Nanoparticular Codelivery System for Enhanced Antitumor Effects by Ferroptosis–Apoptosis Synergistic with Programmed Cell Death-Ligand 1 Downregulation. ACS Nano, 18(26), 17267-17281. https://doi.org/10.1021/acsnano.4c04901

Vancouver

Cao W, Zhang X, Feng Y, Li R, Lu A, Li Z, et al. Lipid Nanoparticular Codelivery System for Enhanced Antitumor Effects by Ferroptosis–Apoptosis Synergistic with Programmed Cell Death-Ligand 1 Downregulation. ACS Nano. 2024;18(26):17267-17281. doi:10.1021/acsnano.4c04901

BibTeX
@article{Cao2024,
  author = {Cao, Weiran and Zhang, Xue and Feng, Yaxuan and Li, Rui and Lu, An and Li, Zijie and Yu, Fei and Sun, Lu and Wang, Jiancheng and Wang, Zhiyu and He, Huining},
  title = {Lipid Nanoparticular Codelivery System for Enhanced Antitumor Effects by Ferroptosis–Apoptosis Synergistic with Programmed Cell Death-Ligand 1 Downregulation},
  journal = {ACS Nano},
  year = {2024},
  volume = {18},
  number = {26},
  pages = {17267--17281},
  doi = {10.1021/acsnano.4c04901}
}
Kostenlos starten →